[PLACE]
Songdo Bio Campus II
Featured in 1 tracked story · first seen
Situations
Samsung Biologics expansion and PolyPeptide acquisition
3 clusters · 13 sources · last updated
Latest: Samsung Biologics launches CHF 1.46 billion tender offer for PolyPeptide Group
Samsung Biologics has launched a public tender offer to acquire the Swiss-based peptide contract development and manufacturing organization (CDMO), PolyPeptide Group, through its subsidiary Samsung Peptide AG. The offer